Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.

por Jonas Söderholm, Jesper Waldenström, Galia Askarieh, Massimo Pilli, Pierre-Yves Bochud, Francesco Negro, Jean-Michel Pawlotsky, Stefan Zeuzem, Carlo Ferrari, Carlo Ferrari, Gunnar Norkrans, Rune Wejstål, Johan Westin, Avidan U Neumann, Bart L Haagmans, Magnus Lindh, Gabriele Missale, Kristoffer Hellstrand, Martin Lagging
Publicado 2013

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.

por Vijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, Kate S O'Connor, Thomas Berg, Martin Weltman, Maria Lorena Abate, Ulrich Spengler, Margaret Bassendine, Gregory J Dore, William L Irving, Elizabeth Powell, Margaret Hellard, Stephen Riordan, Gail Matthews, David Sheridan, Jacob Nattermann, Antonina Smedile, Tobias Müller, Emma Hammond, David Dunn, Francesco Negro, Pierre-Yves Bochud, Simon Mallal, Golo Ahlenstiel, Graeme J Stewart, Jacob George, David R Booth, International Hepatitis C Genetics Consortium (IHCGC)
Publicado 2011